Silencing HIF-1α Makes Erlotinib Work Better Against Lung Cancer Cells
A new cell-line study reports that silencing HIF-1α with siRNA synergizes with erlotinib to suppress proliferation, invasion and glycolysis in ...
Tag: EGFR tyrosine kinase inhibitor
POPULAR NEWS
-
Global Financing Facility falls short on adolescent health funding in three country case studies
-
Prostate Cancer Detection Rose After MRI Arrived, But a Single-Centre Study Says the Reason Stays Unclear
-
Midday Sunlight Yields Smaller Copper Nanoparticles With Stronger Antibacterial Activity
-
Never-Smoker COPD Shows Stronger Lung Function Gains from Salbutamol and Glycopyrronium